Ovarian Cancer

⁦@US_FDA⁩ ‘s Withdrawal of Later-Line Indication For #Olaparib in #BRCA Mutated #OvarianCancer ⁦@OncLive⁩ #gyncsm #womenshealth #cancerresearch #PARP https://t.co/MY9RghtCLp (@LguzzardiM)

Great start to the #nrgoncology Summer Symposium on Rare Tumors. Dr. Lauren Grisham highlights active study NRG-GY019 evaluating the use of Letrozole vs chemo in the initial managment of low grade serous ovarian cancer. This study by @amandanfader and colleagues will answer a… https://t.co/8O9szdMKYS (@JCohenMD)

Listen to our https://t.co/PWWDVFqRNf @SGO_org @gynoncjnls to help manage #TKI toxicity in #gyncancer @TeamEndo_MSK @TeamOvary_MSK @Gyne_Oncology @gyncsm @RenUrban30 @BJRimelMD @MSKCancerCenter (@ROCearbhaill)

A preoperative nomogram incorporating CT to predict the probability of ovarian clear cell carcinoma https://t.co/eEZL2olMKS unique opportunity lead by Dr. Hricak with @natallyhorvat @dchimd @TeamOvary_MSK 🙌 (@PCausaAndrieuMD)

Study results from @LurieCancer’s @GaryESchiltz & @matei_dem indicate that development of TG2 degraders could be a new strategy for reducing dissemination of #ovariancancer https://t.co/Z8BmDo3ZOI via #JMedChem #gyncsm #PROTACs (@LurieCancer)

Yes, it is as described by #OGlehen But not following one imp tip by @glehenolivier - Pringle's manoeuvre to minimise blood loss Works very well for infiltrative deposits in ovarian cancer and PMP of course (@PSOGI_EC)

Tempted to share a couple- not for peritoneal mesothelioma but ovarian cancer Dissection of the Morrison's pouch (dissecting lateral to medial) and digital glissonectomy (right lobe; partial) (@PSOGI_EC)

Submit an abstract by July 18 for the AACR Special Conference on Ovarian Cancer (October 5-7, Boston), chaired by @FrancesBalkwill, @DrBenNeel, @KunleOdunsiMD, and @SwisherLiz. Learn more: https://t.co/RUo2dBskuM #AACRovc23 @SwisherLab (@AACR)

🎙️Don’t miss this podcast with @ShannonWestin on the very interesting concept of neoadjuvant PARPi for women w #OvarianCancer #Oncology #ObGynTwitter @GynMe4 @MDAndersonNews @ASCO @ungkreft @gyncsm @Gynkreft @Cancertrial_ous (@agz_eriksson)

📣 Is the sooner the better? Listen to @ShannonWestin discuss the #NOWtrial in which #PARPi are used in neoadjuvant setting in #ovariancancers with @pedroramirezMD 🔗 https://t.co/A1oVEla0FR @mdandersonnews @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety… https://t.co/c7Dr0nd2ly (@IJGConline)

Olaparib 💊 for neoadjuvant treatment of ovarian cancer!? In this podcast @ShannonWestin discusses with @pedroramirezMD the NOW trial 💥 📌https://t.co/5i99X3tfl4 @IJGConline @HsuMd @JayrajAarthi @AndreFernandes2 @IGCSociety @ESGO_society @ENYGO_official @IJGCfellows @GynMe4 (@GuidoReyv)

Learn how to overcome the challenges and issues related to implementing recommendations from the ESMO Guidelines in a real-world #ovariancancer case. ⏰ 25 July at 18:30 CEST Register now with your free ESMO account 👉 https://t.co/FgJXx8zHgf @CoquardRay @bpellegrino89 #GynCSM (@myESMO)

Time for the ovarian #cancer session with super @BanerjeeSusana at @myESMO course in medical #oncology for medical students #ESMOYOC #ResearchSavesLives @AndresC27622123 (@matteolambe)

Isolated deposits in ovarian cancer in an apparently early stage Ca ovary in the lesser sac ,lesser Omentum and the posterior wall of the stomach. Very important to open and explore these areas!@indepso @anik0411 @NinadKatdare @sugoor_pavan @Sunainawadhwa7 @DrRichaBansal (@rohitranade)

WATCH: Dr @ShannonWestin explains the data on treatment of rare tumors in #OvarianCancer and why biomarker testing is essential. #oncology #gyncsm https://t.co/96gCaI45Nt (@OncLive)

Submit an abstract by July 18 for the AACR Special Conference on Ovarian Cancer (October 5-7, Boston), chaired by @FrancesBalkwill, @DrBenNeel, @KunleOdunsiMD, and @SwisherLiz. Learn more: https://t.co/OJJnq2BQc0 #AACRovc23 @SwisherLab (@AACR)

What should patients know about #ovariancancer and hereditary risk? Dr. Hoskins @drebonyhoskins of @MedStarWHC shares the incidence rate and genetic testing advice. https://t.co/Hiv0ZL1HJG #gyncsm (@power4patients)

I regard ovarian cancer and MPM similarly. The goal is always complete cyto with no visible disease remaining. But there are some patients where diffuse small nodules make this impossible. I will attempt to achieve a CC1 cyto with small volume visible disease left behind. (@PSugarbaker)

Malignant peritoneal mesothelioma and advanced ovarian cancer can have identical clinical manifestations. Accurate pathology and high index of suspicion are essential. This error in diagnosis occurs repeatedly. (@PSugarbaker)

@PSugarbaker #PSOGICASE February 27, 2018: PET-CT was performed that showed progression of the disease within the pelvis. A decision was made that the systemic chemotherapy for presumed ovarian malignancy was ineffective. @LanaBijelicMD @alarjosan @FaheezM @KurtSpeeten @FaekJ (@PSOGI_EC)

Honored to be on the @FacingOurRisk blog! Our intense song “Mutant” is about my #BRCA mutation and was recorded by mother & daughter together: https://t.co/7OpFSjDJLU @geneticcouns @karenlumd #ovariancancer @GildasClubNYC @joliestweet @mathewknowles @1capplegate @themorganwade (@the_mothermold)

It's always a good day to honor #teal, to Talk About #OvarianCancer and to celebrate life - with special thanks to our Advisory Board Member, Dr. @AnilSoodMD for his steadfast guidance to Ovarcome over the years. 🙏 THIS is how #WeOvarcome ! 💙 (@ovarcome)

Register by August 28 to get the lowest rates for the AACR Special Conference on Ovarian Cancer (October 5-7, Boston), chaired by @FrancesBalkwill, @DrBenNeel, @KunleOdunsiMD, and @SwisherLiz. Learn more: https://t.co/vkil2iOveT #AACRovc23 @SwisherLab (@AACR)

What #ovariancancer risk factors should patients know about? @drebonyhoskins of @MedStarWHC shares common risk factors and patient advice. https://t.co/2QW9iR6aNe #gyncsm (@power4patients)

Validation of the #Integrated #Prediction Model algorithm for outcome of #cytoreduction in advanced #ovarian #Cancer 🔗 https://t.co/Wwc9Vvo0oO @sabrinapiedimo1 @pedroramirezMD @HsuMd @JayrajAarthi @AndreFernandes2 @agz_eriksson @IGCSociety @ESGO_society @ENYGO_official… https://t.co/cqfuysnjd5 (@IJGConline)

@joellaang @wangjj in the boxing ring! Upfront crs vs neoadjuvant chemo for ovarian cancer. Who came out tops? Let me know your thoughts! @somusp9 @Jolenewongsm @JohnnyOngCA @JaneSeo21 https://t.co/DNOAFOagZA (@ChiaClaramae)

That's right, these cystic neoplasms are the most frequent ovarian tumors, accounting for 40% of all ovarian cancers, and the estimated risk of ovarian cancer in these mutations is 20 to 60% at 70 years. (@Carlos_Amez0289)

Submit an abstract by July 18 for the AACR Special Conference on Ovarian Cancer (October 5-7, Boston), chaired by @FrancesBalkwill, @DrBenNeel, @KunleOdunsiMD, and @SwisherLiz. Learn more: https://t.co/EMduznhLtb #AACRovc23 @SwisherLab (@AACR)

What are the subtypes of #ovariancancer? @drebonyhoskins of @MedStarWHC explains what patients need to know and shares questions to ask your doctor. https://t.co/5gL7t36WcE #gyncsm (@power4patients)

Thanks for interacting w/ a past #gyncsm chat - hope to see you for our next chat Wed 7/12 8pmET. @EK_Drake @Kandigyrl3 @ArturPrusaczyk @IvyRadOncMD @rubycarrion_ @PowerOvarian @FayUCCancerCr @sharron138 @_GeorgiaHurst @PublicHealthMap @OncologyFACETS @kquinlan35 @UFHealthCancer (@btrfly12)

Avutometinib + defactinib elicited high responses among patients w/ recurrent low grade serous ovarian cancer vs avutometinib monotherapy, supporting the use of the combination. @BanerjeeSusana @royalmarsdenNHS #ovca https://t.co/6LPaFtJlGv (@OncLive)

Second-line maintenance therapy with niraparib improved overall survival vs active surveillance in patients with recurrent BRCA wild-type ovarian cancer. @rcoledude #ovca #ASCO23 https://t.co/MNEYhPArVr (@OncLive)

What are some current unmet needs in the maintenance setting for ovarian cancer? Here, our Dr. Shannon Westin shares her insights: https://t.co/y61pNv70LJ @OncLive @ShannonWestin #OvarianCancer #EndCancer (@MDAndersonNews)

#GSK Satellite Symposium Controversies in Ovarian and Endometrial Cancer. Imagining the Management of These Patients #IAOC2023 https://t.co/k808kQDiBI @AnaOaknin Dr Gonzalo Gómez Abuin (@IAOC_Conference)

Breast & Gynecological Cancer New Drugs and Treatments in Breast Cancer Novel Approaches in the Management of Ovarian and Cervical Cancer #IAOC2023 #BreastCancer #OvarianCancer #CervicalCancer Dr Carlos Barrios @AnaOaknin Dr Valeria Cáceres (@IAOC_Conference)

Submit an abstract by July 18 for the AACR Special Conference on Ovarian Cancer (October 5-7, Boston), chaired by @FrancesBalkwill, @DrBenNeel, @KunleOdunsiMD, and @SwisherLiz. Learn more: https://t.co/Ag0y4lypvV #AACRovc23 @SwisherLab (@AACR)

What are the #ovariancancer stages, and what do patients need to know about them? Dr. Hoskins @drebonyhoskins of @MedStarWHC shares an overview and why staging is important. https://t.co/1ypI5zBrna #hyncsm (@power4patients)

#KELIM a new and robust biomarker for ovarian cancer to predict the outcomes of first line therapy @benoityoulyon @RENAPE_Network @CHUdeLyon @IJGConline @BatistaTP @agz_eriksson @JayrajAarthi @Bhandoria @gyncsm @GynMe4 @esragbilir @AndreasObermair @uppals (@PSOGI_EC)

#Tcells T cells #leukemia #leukaemia #cancer #autoimmune #autoimmunity #immunotherapy #bladdercancer stomach cancer #braincancer #breastcancer #midwifery #childhoodcancer uterine cancer #coloncancer #kidneycancer #livercancer #lymphoma #myeloma pancreatic cancer #ovariancancer (@SilkeLeFay)

Check out our new publication about PARPi in ovarian cancer https://t.co/jBJVUcM7tW. I’m so lucky to have met and worked with @FelipeBatalini and @laerciolopesMD who are such an inspiration to me. #LatinosInOncology (@LetyCampoverde)

Submit an abstract by July 18 for the AACR Special Conference on Ovarian Cancer (October 5-7, Boston), chaired by @FrancesBalkwill, @DrBenNeel, @KunleOdunsiMD, and @SwisherLiz. Learn more: https://t.co/so6A4tsaQH #AACRovc23 @SwisherLab (@AACR)

Controversies in Ovarian Cancer at GSK Satellite Symposium at the 10th IAOC Conference #OvarianCancer #EndometrialCancer @AnaOaknin Dr. Gonzalo Gómez Abuin (@IAOC_Conference)